Alto Neuroscience, Inc.'s total assets for Q4 2025 were $184.69M, an increase of 25.63% from the previous quarter. ANRO total liabilities were $33.55M for the fiscal quarter, a -5.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.